News Column

Tianjin Ringpu 2013 Net Expected to Up 2%-10%

January 20, 2014

TIANJIN , January 20 , SinoCast -- Tianjin Ringpu Bio-technology Co., Ltd. (SZSE: 300119) predicted that operating revenue will rise 10% to 20% in 2013, when net profit attributable to shareholders will range between CNY 146.96 million and CNY 158.49 million , hiking 2% to 10% from a year earlier. In 2013, no-recurring profit and loss reached CNY 21.5 million , mainly from capital support to scientific and technology innovation and service development.


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Sinocast Health Care & Medicine Beat (China)


Story Tools